Understanding the impact of calcitonin gene-related peptide antagonist Rimegepant on cognitive function and mood in people with migraine

Researchers

Grant status

Active

Grant start date

29/12/2023

Grant funding

  • 2024: $82,085 from Pfizer Inc

Updated:  05 July 2024 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers